DocGo Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M | $94.1M |
| Cost of Revenue | — | — | — | $523.9M | $451.7M | — |
| Gross Profit | — | — | — | $-83.4M | $-133.0M | — |
| Gross Margin | — | — | — | -18.9% | -41.7% | — |
| Operating Expenses | ||||||
| Research & Development | $13.6M | $11.6M | $10.9M | $5.4M | $3.3M | $1.2M |
| SG&A Expense | $133.4M | $138.8M | $137.2M | $103.4M | $74.9M | $34.9M |
| Operating Income | $-178.0M | $28.7M | $15.1M | $21.8M | $15.4M | $-14.8M |
| Operating Margin | -55.3% | 4.7% | 2.4% | 5.0% | 4.8% | -15.7% |
| Interest Expense | — | — | — | $117.7K | $61.3K | $15.8K |
| Pretax Income | $-187.5M | $27.7M | $16.3M | $22.8M | $19.8M | $-14.6M |
| Income Tax Expense | $8.9M | $14.4M | $6.2M | $-8.0M | $615.7K | $167.4K |
| Net Income | $-182.4M | $20.0M | $6.9M | $34.6M | $23.7M | $-14.8M |
| Net Margin | -56.6% | 3.2% | 1.1% | 7.9% | 7.4% | -15.7% |
| EPS (Basic) | $-1.84 | $0.20 | $0.07 | $0.34 | $0.30 | $-0.25 |
| EPS (Diluted) | $-1.84 | $0.18 | $0.06 | $0.34 | $0.25 | $-0.25 |
| Shares Outstanding (Basic) | 99.1M | 102.4M | 103.5M | 101.2M | 80.3M | 58.4M |
| Shares Outstanding (Diluted) | 99.1M | 109.4M | 105.6M | 103.0M | 94.9M | 58.4M |
| Dividends Per Share | — | — | — | — | — | — |